Showing results (31-40 of 839) with videos related to
Sort By:
Pageof 84
Vaccine|March 21, 2001
Monitoring of measles elimination using molecular epidemiologyM N Mulders, A T Truong, C P MullerJournal of Immunology (Baltimore, Md. : 1950)|January 1, 1986
Changes in mouse MHC expression during the cell cycle of Con A-treated spleen cellsC P Muller, D A Stephany, J R WunderlichAvian Diseases|May 8, 2008
Molecular epidemiology of chicken anemia virus (CAV) in southeastern Chinese live birds marketsM F Ducatez, H Chen, Y Guan, et al.European Journal of Haematology|September 1, 1989
Hypocholesterolemia, an unfavorable feature of prognostic value in chronic myeloid leukemiaC P Muller, A U Wagner, C Maucher, et al.Anticancer Research|March 1, 1991
Enhanced antigenicity of autologous leukemia cells enriched with cholesterylhemisuccinateC P Muller, D Treiber, B Steinke, et al.Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|January 1, 1990
[Importance of DNA-cytometric parameters in the prediction of blast crisis in the course of chronic myelogenous leukemia]M Kropff, T Wenzler, A Wagner, et al.Plant Molecular Biology|March 26, 2003
Neutralizing immunogenicity of transgenic carrot (Daucus carota L.)-derived measles virus hemagglutininE Marquet-Blouin, F B Bouche, A Steinmetz, et al.Journal of Virological Methods|October 8, 1998
A simplified immunoassay based on measles virus recombinant hemagglutinin protein for testing the immune status of vaccineesF Bouche, W Ammerlaan, P Fournier, et al.Clinical and Experimental Immunology|November 20, 1998
Processing of the DRB1*1103-restricted measles virus nucleoprotein determinant 185-199 in the endosomal compartmentS Demotz, W Ammerlaan, P Fournier, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1983
Changes in cell-surface expression of MHC and Thy-1.2 determinants following treatment with lipid modulating agentsC P Muller, D A Stephany, M Shinitzky, et al.Pageof 84